Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing (FIT) could potentially match colonoscopy for reducing long-term colorectal cancer (CRC) incidence and ...

Annual fecal immunochemical test-based surveillance could be as effective as colonoscopies in reducing long-term colorectal cancer incidence and mortality, according to a recent study published in ...

Most Americans hear "colorectal cancer screening" and think "colonoscopy" -- the unpleasant cleanse, the snakelike scope, the wobbly ride home. It's a process that's undeniably inconvenient, yet one ...

Timely follow-up colonoscopies can reduce the mortality rate from colorectal cancer, and patient navigators can play an important role in facilitating screening, according to researchers at the U of A ...

Please provide your email address to receive an email when new articles are posted on . Interval FIT was positive in 14% to 17% of patients after colonoscopy, regardless of polypectomy history. High ...

Please provide your email address to receive an email when new articles are posted on . A patient navigation program addressed barriers to getting a colonoscopy, including insurance and transportation ...

Post-COVID-19, colonoscopy and FIT usage declined, while stool DNA testing increased among privately insured adults. Screening preferences varied by sex, socioeconomic status, and metropolitan versus ...

SAN DIEGO — For patients with a positive fecal immunochemical test, the risk for colorectal cancer increases if diagnostic colonoscopy is delayed beyond 6 months, according to new research. "In breast ...